PapIG, HPV, rfx 16/18 — Pap Smear With Reflex HPV Genotyping, Explained

Your cervical cancer screening report came back with a line that looks like a string of code: PapIG, HPV, rfx 16/18. It is one of the most confusing-looking results on any lab report — not because the medicine is complicated, but because the label is compressed into abbreviations. This page reads that label back to you, left to right, and then explains what each result means.

The one idea that explains this whole page: This label describes a workflow, not one result. Read it as three steps in order: examine the cervical cells (Pap), test the same sample for high-risk HPV, and — if the panel's reflex criteria are met — report whether HPV 16 or 18 specifically is present.

At a glance

• It is a bundle, not a single test. An image-guided, liquid-based ThinPrep Pap and a high-risk HPV screen run on the same sample, plus a conditional genotype follow-up that reports HPV 16 and 18 as distinct types.
• "rfx" means reflex — an automatic follow-up result that is released only if the earlier results meet the panel's criteria. Nothing extra is ordered by you.
• 16 and 18 are the two HPV types singled out because they cause most cervical cancers.
• A single stored "Negative" or "Positive" does not say which component it represents — check the source report and read it with the other lines, not alone.
• This screens and triages; it does not diagnose. A positive result means look closer, not cancer.
• Your screening history can materially change the next step — the same current result can point different ways depending on what came before.

Reading the label, piece by piece

IGP / PapIG / "Pap, IG" — this is the Pap smear (Papanicolaou test). "IG" or "image-guided" refers to how the slide is read; the substance is the same familiar Pap: cells are brushed from the cervix and examined for abnormal changes. This is the "look at the cells" step.

HPV — human papillomavirus, screened from the same sample. This looks for the virus that causes nearly all cervical cancer, rather than the cell changes it may eventually produce. The initial high-risk HPV screen checks a pool of high-risk types together and reports them as a group, without naming which one.

rfx / Rfx / "reflex" — the piece that confuses the most people, and it is simple: "reflex" means a follow-up result that is released automatically, but only if an earlier result meets a set condition. Nothing extra is ordered by you or your doctor. If the panel's reflex criteria are met, the lab reflexes — reaches back to the same sample — and reports the 16/18 result. If they are not met, no separate 16/18 result is reported.

16/18 — the two HPV genotypes the reflex reports specifically, each named on its own. Of the high-risk HPV types, 16 and 18 cause the majority of cervical cancers, so when the reflex runs, these two are singled out and reported as distinct results (this panel does not pool 18 with any other type).

What "rfx" means on any lab report

Many people reach this page just to learn what the word "reflex" (rfx) means — it appears on many lab panels, not only this one. A reflex test is a conditional second step: if a first result meets a set condition, the lab automatically runs a follow-up on the same sample. Rfx, rflx, and reflex all mean the same thing.

What this panel is actually testing

The Pap and the HPV screen answer different questions. The Pap here is a liquid-based ThinPrep sample read with an image-guided system, and it asks have the cells started to change? The HPV screen asks is a high-risk type present? — it checks a pool of recognized high-risk HPV types and reports them together, without naming which one. Because HPV usually comes first and cell changes come later, the two findings triage each other: a worrying cytology with no virus, and a virus with normal cytology, are handled very differently from both together.

The reflex adds a third layer when the panel's reporting criteria are met. The source report confirms that HPV 16 and HPV 18 appear as separate results, but the supplied evidence does not establish the exact trigger for order code 197146. To understand why a genotype result was or was not reported, read the preceding Pap and pooled-HPV lines.

Reading the result combinations

Which parts are positive — and your screening history — is what matters, not any single line alone. The pathways below follow current ASCCP risk-based guidance:

These are orientation examples, not a personal recommendation. ASCCP management is risk-based: age, prior HPV-based results, previous colposcopy or treatment, pregnancy, and immune status can each change the next step, and history can materially change it. One nuance worth knowing: a recent negative HPV-based test lowers risk enough to defer colposcopy only when that test was done for routine screening, not surveillance of a previous abnormality — and this deferral applies to non-16/18 high-risk HPV. A positive HPV 16 or 18 is the exception: current guidance directs colposcopy even with normal or low-grade cytology, regardless of a recent negative screen. (Pathways per the 2019 ASCCP guideline and CDC's comparison table; see references.)

Reading your value

This panel does not produce a number. Each component reports a category — the Pap as a Bethesda category (e.g. NILM, ASC-US, LSIL), the HPV screen as Negative or Positive, and the reflex as 16 reported / 18 reported / neither. In the dashboard, the stored result is a single Negative / Positive — but the current mapping does not establish which component that stored word represents, so check the source report and read it against the full result rather than treating it as a verdict on the whole panel. A screenshot or PDF of the actual result is what your clinician will want to see.

Two people, the same "HPV positive"

Person A is 32. Her Pap is normal and her high-risk HPV screen is positive, but neither HPV 16 nor HPV 18 was reported. This means another high-risk type was detected while cytology remained normal. For an average-risk patient without modifying history, current guidance generally calls for HPV-based testing in one year rather than immediate colposcopy.

Person B is also 32, also with a normal Pap, but her reflex reports HPV 16 positive. Same "HPV positive" headline, different path: because 16 is one of the two highest-risk types, current ASCCP guidance generally directs her toward colposcopy now, even with a normal Pap. Same screen, same normal cytology — the genotype is what separates the two next steps.

Neither result is a cancer diagnosis. The genotype, the cytology, and each person's history — read together — set the pace of what comes next.

What this test cannot tell you

It cannot diagnose cancer. It is a screen and a triage: colposcopy takes a closer look at the cervix, and a biopsy is what provides a diagnosis. A positive result says look closer, not you have cancer.

It cannot tell you how long you have had HPV, or from whom. HPV is extremely common and often silent for years; a first-time positive does not date the infection.

It cannot, from a single stored word, tell you the whole panel is clear. The current mapping does not establish which component that stored value represents; the other lines on the report still have to be read.

It cannot replace the screening schedule. A negative result is reassuring for the interval your clinician sets, not permanently.

Common interpretation mistakes

Reading "HPV positive" as a cancer diagnosis. It is not. A common virus was detected; most infections clear, and the panel exists to sort the few that need attention.

Reading a single "Negative" as a whole-panel all-clear. The current mapping does not establish which component the stored value represents. A negative HPV screen means a high-risk type was not detected — it does not by itself establish that the Pap was normal. Check both lines on the report.

Reading "positive but 16 and 18 negative" as bad news. This is often reassuring — a high-risk type is present but not the two most dangerous ones. With a normal Pap it usually means watchful repeat testing, not a procedure.

Thinking the reflex test "failed" when it didn't run. "Reflex criteria not met" means the conditions for the follow-up were not satisfied — check the HPV and cytology lines. It is not a failed or missing test.

Ignoring screening history. The same current result can mean colposcopy or one-year surveillance depending on your prior HPV-based results. History is part of the interpretation, not a footnote.

Questions your doctor may ask

Which parts were positive — the Pap, the HPV screen, or the 16/18 genotype? The combination sets the next step.

What did your previous screening show, and when? For non-16/18 high-risk HPV, a recent documented negative HPV test can move a low-grade result from colposcopy to one-year surveillance (a positive 16 or 18 generally goes to colposcopy regardless).

Have you had abnormal Pap or HPV results before? Persistence over time changes management more than any single result.

Do you have the actual report? The Bethesda category and the specific genotype matter; the single word "positive" is not enough.

Read together with

Cervical cytology (Pap) result — the cell-level half of this panel; read alongside the HPV result, never alone.

High-risk HPV genotype (16/18) — the reflex component that singles out the two highest-risk types when the reflex runs.

Colposcopy / biopsy results — the step this screen may lead to; colposcopy examines the cervix more closely and the biopsy provides the diagnosis, while this screen only flags risk.

Clinical pearls

This is a co-test: cytology plus high-risk HPV, read together. Neither half is interpreted alone, and the current mapping does not establish which component a single stored result represents — check the source report.

"Reflex" is conditional reporting — a separate 16/18 result is released only when the panel's reflex criteria are met. A report that says the criteria were not met does not by itself indicate a failed test; the preceding HPV and cytology lines are needed to understand why.

16 and 18 are singled out because they cause most cervical cancers. A positive 16 or 18 generally warrants colposcopy even when cytology is normal.

Management is risk-based, and history can materially change the next step. The same current result can mean colposcopy or one-year surveillance depending on prior HPV-based screening — though a positive HPV 16 or 18 generally goes to colposcopy regardless.

Current US guidance now prefers primary HPV testing; co-testing is an accepted alternative. A patient's result is read against their history and current ACS/ASCCP guidance.

In one sentence

A bundled cervical screen — Pap plus high-risk HPV — that automatically reports HPV 16 and 18 when its reflex criteria are met, to sort common infection from the few cases that need a closer look.

The bottom line

PapIG, HPV, rfx 16/18 describes a workflow, not one result: look at the cervical cells, test for high-risk HPV, and report HPV 16 and 18 if the reflex criteria are met. Most results are reassuring — a fully confirmed negative means routine rescreening, and even "HPV positive" often means watchful repeat testing rather than a procedure. What raises the pace is a combination whose ASCCP risk estimate crosses the colposcopy threshold — a positive 16 or 18, high-grade cytology, or a low-grade result without a recent documented negative screen; other low-grade combinations may instead receive one-year surveillance. Read the parts together, remember that a single stored word doesn't say which component it represents, bring the actual report to your clinician, and let current ACS/ASCCP guidance applied to your history set the next step.

Clinical Takeaway. A single Negative or Positive is not enough to interpret this panel. First identify whether it belongs to the cytology, the pooled HPV screen, or a genotype result; then read it with the other components and your prior screening history. The panel screens and triages — it does not diagnose — and history can materially change the next step.